Research Examining Gilteritinib In Newly Diagnosed AML

John Burke, MD Hematologist/Oncologist and Associate Chair of the US Oncology Hematology Research Program, Rocky Mountain Cancer Centers Discusses Research Examining Gilteritinib In Newly Diagnosed AML At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com